• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Cellerant Therapeutics

edit

Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.

Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. And we are applying our expertise in hematopoietic ontogeny to identify novel drug targets and therapeutic antibodies aimed at cancer stem cells.

Recent Milestones

edit

• 
  Cellerant Therapeutics received $16.7M in Grant funding. (9/15/11)
  Posted 9/15/11 at 7:16pm via dowjones.com
• 
  Cellerant Therapeutics — Cellerant lands $153M BARDA contract for ARS program (9/1/10)
  Posted 9/6/10 at 7:24am via fiercebiotech.com
• 
  Cellerant Therapeutics received $4.4M in Series B funding. (4/26/07)
  Posted 9/12/09 at 7:15am via venturebeat.com
• 
  Cellerant Therapeutics received $16M in Series B funding. (5/11/05)
  Posted 7/2/10 at 12:45am via cellerant.com
• 
  Cellerant Therapeutics added William Reed as Vice President for Clinical Development.
  Posted 4/22/13 at 11:27am
• 
  Cellerant Therapeutics added Sean Givens as Vice President of Government Operations and Controller.
  Posted 4/22/13 at 11:27am
• 
  Cellerant Therapeutics added Jun S.Yoon as Vice President, Corporate Development.
  Posted 4/22/13 at 11:27am
• 
  Cellerant Therapeutics added Gautam Banik as Executive Director of Manufacturing and Process Sciences.
  Posted 4/22/13 at 11:27am
• 
  Cellerant Therapeutics added Rob Tessler as Vice President of Research & Development .
  Posted 4/22/13 at 11:27am
• 
  Cellerant Therapeutics added Margaret Dillon as Sr. Vice President, Regulatory, QA & Project Management.
  Posted 4/22/13 at 11:27am
• 
  Cellerant Therapeutics added Lowell Sears as Chairman, Board of Directors.
  Posted 6/14/12 at 5:35pm
• 
  Cellerant Therapeutics added Ram Mandalam as President & CEO Board of Director.
  Posted 6/14/12 at 5:35pm
• 
  Cellerant Therapeutics added Richard Chyette as Board Of Directors.
  Posted 4/22/13 at 11:31am
• 
  Cellerant Therapeutics added Steve Greenberg as Board Of Directors.
  Posted 4/22/13 at 11:31am
• 
  Cellerant Therapeutics added Richard G.Rathmann as Board Of Directors.
  Posted 4/22/13 at 11:31am
• 
  Cellerant Therapeutics added Gisela S. Schwab as Board Of Directors.
  Posted 4/22/13 at 11:31am

Videos

Screenshots

edit

Sources

1. CELLERANT THERAPEUTICS RAISES $16 MILLION TO ADVANCE STEM CELL-BASED THERAPIES FOR LIFE-THREATENING DISEASES (cellerant.com) [edit]
2. Cellerant Therapeutics raises $4.4M for stem-cell therapeutics (deals.venturebeat.com) [edit]
3. Cellerant Thera Awarded Additional $16.7M For Radiation Treatment (fis.dowjones.com) [edit]
Cellerant lands $153M BARDA contract for ARS program (fiercebiotech.com) [edit]